JP4801948B2 - Method for changing the content ratio of catechins in tea leaves and tea extracts - Google Patents
Method for changing the content ratio of catechins in tea leaves and tea extracts Download PDFInfo
- Publication number
- JP4801948B2 JP4801948B2 JP2005228631A JP2005228631A JP4801948B2 JP 4801948 B2 JP4801948 B2 JP 4801948B2 JP 2005228631 A JP2005228631 A JP 2005228631A JP 2005228631 A JP2005228631 A JP 2005228631A JP 4801948 B2 JP4801948 B2 JP 4801948B2
- Authority
- JP
- Japan
- Prior art keywords
- tea
- egc
- tea leaves
- catechins
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 title claims description 59
- 235000005487 catechin Nutrition 0.000 title claims description 59
- 150000001765 catechin Chemical class 0.000 title claims description 44
- 238000000034 method Methods 0.000 title claims description 42
- 239000000284 extract Substances 0.000 title description 37
- 241001122767 Theaceae Species 0.000 title 2
- 244000269722 Thea sinensis Species 0.000 claims description 135
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 46
- 238000000855 fermentation Methods 0.000 claims description 25
- 230000004151 fermentation Effects 0.000 claims description 25
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 16
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 16
- 230000009471 action Effects 0.000 claims description 14
- 235000000346 sugar Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 7
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 138
- 235000013616 tea Nutrition 0.000 description 132
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 71
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 71
- 241000233866 Fungi Species 0.000 description 45
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 38
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 37
- 229940030275 epigallocatechin gallate Drugs 0.000 description 37
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 36
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 35
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 35
- 235000012734 epicatechin Nutrition 0.000 description 35
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 25
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 25
- 235000019225 fermented tea Nutrition 0.000 description 21
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 16
- 229950001002 cianidanol Drugs 0.000 description 15
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 14
- 244000294411 Mirabilis expansa Species 0.000 description 11
- 235000015429 Mirabilis expansa Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 235000013536 miso Nutrition 0.000 description 11
- 108010016731 PPAR gamma Proteins 0.000 description 10
- 102000012132 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 230000003078 antioxidant effect Effects 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 8
- 240000006439 Aspergillus oryzae Species 0.000 description 7
- 238000009825 accumulation Methods 0.000 description 7
- 235000019606 astringent taste Nutrition 0.000 description 7
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 210000000229 preadipocyte Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000000644 propagated effect Effects 0.000 description 4
- 235000020083 shōchū Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- -1 gallate ester Chemical class 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 238000004811 liquid chromatography Methods 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000004904 shortening Methods 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 2
- 241000374462 Aspergillus pseudoglaucus Species 0.000 description 2
- 241000209507 Camellia Species 0.000 description 2
- 241000235646 Cyberlindnera jadinii Species 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 235000018597 common camellia Nutrition 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 230000006377 glucose transport Effects 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000009283 thermal hydrolysis Methods 0.000 description 2
- 229930013783 (-)-epicatechin Natural products 0.000 description 1
- 235000007355 (-)-epicatechin Nutrition 0.000 description 1
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 1
- XMOCLSLCDHWDHP-DOMZBBRYSA-N (-)-gallocatechin Chemical compound C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-DOMZBBRYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 241001327634 Agaricus blazei Species 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000216654 Armillaria Species 0.000 description 1
- 244000221226 Armillaria mellea Species 0.000 description 1
- 235000011569 Armillaria mellea Nutrition 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241001513093 Aspergillus awamori Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241001112078 Aspergillus usamii Species 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001042096 Cyberlindnera tropicalis Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 241001537207 Flammulina Species 0.000 description 1
- 240000006499 Flammulina velutipes Species 0.000 description 1
- 235000016640 Flammulina velutipes Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000222684 Grifola Species 0.000 description 1
- 240000001080 Grifola frondosa Species 0.000 description 1
- 235000007710 Grifola frondosa Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- 241000222418 Lentinus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 241000896238 Oidium Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- 241000722337 Pholiota Species 0.000 description 1
- 244000168667 Pholiota nameko Species 0.000 description 1
- 235000014528 Pholiota nameko Nutrition 0.000 description 1
- 241000222350 Pleurotus Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 241000222480 Schizophyllum Species 0.000 description 1
- 241000222481 Schizophyllum commune Species 0.000 description 1
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 239000003529 anticholesteremic agent Substances 0.000 description 1
- 229940127226 anticholesterol agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000011955 best available control technology Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- VFSWRBJYBQXUTE-UHFFFAOYSA-N epi-Gallocatechin 3-O-gallate Natural products Oc1ccc2C(=O)C(OC(=O)c3cc(O)c(O)c(O)c3)C(Oc2c1)c4cc(O)c(O)c(O)c4 VFSWRBJYBQXUTE-UHFFFAOYSA-N 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 235000020344 instant tea Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000013138 pruning Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Landscapes
- Tea And Coffee (AREA)
Description
本発明は、真菌類の発酵作用により、茶葉および茶抽出物におけるカテキン類の含有量比を変化させる方法に関する。 The present invention relates to a method for changing the content ratio of catechins in tea leaves and tea extracts by the fungal fermentation.
緑茶の効用成分として、緑茶に含まれるカテキン類(緑茶カテキン)の抗肥満効果が注目されている。主な「緑茶カテキン」には、エピガロカテキンガレート(EGCg)、エピガロカテキン(EGC)、エピカテキンガレート(ECg)、エピカテキン(EC)、カテキンガレート(Cg)、カテキン(C)、ガロカテキンガレート(GCg)、ガロカテキン(GC)があるが、それぞれ機能性と滋味、特に渋味が異なる(以下、本明細書において各カテキン類を表す場合、括弧内の略語も用いる)。 As an effect ingredient of green tea, the anti-obesity effect of catechins (green tea catechins) contained in green tea has attracted attention. The main “green tea catechins” include epigallocatechin gallate (EGCg), epigallocatechin (EGC), epicatechin gallate (ECg), epicatechin (EC), catechin gallate (Cg), catechin (C), gallocatechin There are gallate (GCg) and gallocatechin (GC), but each has different functionality and taste, particularly astringency (hereinafter, when each catechin is represented in this specification, an abbreviation in parentheses is also used).
最近明らかになっていることとして次の文献を示す。血中コレステロールに関しては、特許文献1は、(−)エピカテキン(EC)に血中コレステロール量低下作用がある旨を開示し、特許文献2は、茶カテキンの中でも特に(−)エピガロカテキンガレート(EGCg)を有効成分とするコレステロール低下剤を開示し、特許文献3は、エピカテキンガレート(ECg)を有効成分とするコレステロール排泄促進剤を開示している。 The following literature is shown as something that has recently become clear. Regarding blood cholesterol, Patent Document 1 discloses that (−) epicatechin (EC) has an effect of lowering blood cholesterol level, and Patent Document 2 particularly describes (−) epigallocatechin gallate among tea catechins. A cholesterol-lowering agent containing (EGCg) as an active ingredient is disclosed, and Patent Document 3 discloses a cholesterol excretion promoter containing epicatechin gallate (ECg) as an active ingredient.
また、摂食後のインスリン分泌量が増大しているモデルでは、ガレートエステルを持つカテキン(EGCg、ECg、Cg、GCg)がグルコース輸送活性を抑制し、定常状態のモデルではインスリン非存在下において、ガレートエステルを持たないカテキン(EGC、EC、C、GC)がグルコース輸送活性を上昇させることが分かっている(非特許文献1)。 In addition, in the model in which the amount of insulin secretion after feeding is increased, catechin having a gallate ester (EGCg, ECg, Cg, GCg) suppresses glucose transport activity, and in the steady state model, gallate is present in the absence of insulin. It has been found that catechins without ester (EGC, EC, C, GC) increase glucose transport activity (Non-patent Document 1).
他に、EGCgに比較してEGCやCgは、マウスの3T3-L1由来前駆脂肪細胞の脂肪滴の蓄積を抑制することやPPARγ(peroxisome proliferator-activated receptor γ)やC/EBPαの発現抑制作用が知られている。PPARγやC/EBPαは糖尿病に深く関連があることが知られており、これらの発現抑制はII型の糖尿病の誘発抑制に効果があると期待されている(非特許文献2、3)。しかし、GCにはこのような効果は認められない。 In addition, compared to EGCg, EGC and Cg inhibit the accumulation of lipid droplets in mouse 3T3-L1-derived preadipocytes, and suppress the expression of PPARγ (peroxisome proliferator-activated receptor γ) and C / EBPα. Are known. PPARγ and C / EBPα are known to be deeply related to diabetes, and suppression of their expression is expected to be effective in suppressing induction of type II diabetes (Non-patent Documents 2 and 3). However, such an effect is not recognized in GC.
一方、「緑茶カテキン」の種類をコントロールし、「緑茶カテキン」のうち特定のものを増大または減少させる方法は、特定のカテキン成分をクロマトグラフ法により分取するという実験室レベルの方法しかなく、これは、製造される茶の安全性および工業的製造の観点から、製造方法としては不適である。 On the other hand, the method of controlling the type of “green tea catechin” and increasing or decreasing the specific one of “green tea catechins” is only a laboratory-level method of fractionating specific catechin components by chromatography, This is unsuitable as a production method from the viewpoint of safety of tea to be produced and industrial production.
上記事情に鑑み、本発明は、茶において薬理効果が期待される特定の微量のカテキン成分の含有量を増大させ、茶葉または茶抽出物におけるカテキン類の含有量比を変化させる方法を提供することを目的とする。本発明の目的の一つは、茶においてEGCの含有量を増大させ、茶葉または茶抽出物におけるカテキン類の含有量比を変化させる方法を提供することである。今日の健康ブームの下では、茶に少量しか含まれないが、その効能が注目されている特定のカテキン成分を茶葉または茶抽出物において増大させ、高い機能性を有する食品を提供することが望まれる。 In view of the above circumstances, the present invention provides a method for increasing the content of a specific trace amount of catechin components expected to have a pharmacological effect in tea and changing the content ratio of catechins in tea leaves or tea extracts. With the goal. One of the objects of the present invention is to provide a method for increasing the content of EGC in tea and changing the content ratio of catechins in tea leaves or tea extracts. Under today's health boom, it is desirable to provide certain foods with high functionality by increasing the specific catechin ingredients that are notable for tea, but for which their efficacy has attracted attention, in tea leaves or tea extracts. It is.
上記課題を解決するために本発明者らは検討を重ねた。すなわち、カテキン類のガレート基の加水分解による特定のカテキン成分の工業的な製造法として、水溶液中での熱加水分解が考えられるが、かかる熱加水分解による方法は、EGCgのガレート基が加水分解されると同時に副反応としてエピメリゼーションが起こり、EGCとGCの比率が約1:1になるため、特定のカテキン成分を特異的に増大させるのには不向きである。また特定のカテキン成分の工業的な製造法として酵素を用いて加水分解を行えば、立体構造を維持したままの加水分解は可能であるが、コストが高い上に、酵素がカテキンにより失活されやすいため、この方法は、特定のカテキン成分を安定して増大させるのには不向きである。 In order to solve the above problems, the present inventors have repeatedly studied. That is, as an industrial production method of a specific catechin component by hydrolysis of a catechin gallate group, thermal hydrolysis in an aqueous solution is conceivable. However, in this method by thermal hydrolysis, the gallate group of EGCg is hydrolyzed. At the same time, epimerization occurs as a side reaction, and the ratio of EGC to GC is about 1: 1, which is not suitable for specifically increasing a specific catechin component. In addition, if an enzyme is used as an industrial production method for a specific catechin component, hydrolysis can be performed while maintaining the three-dimensional structure, but the cost is high and the enzyme is inactivated by catechin. This method is not suitable for stably increasing a specific catechin component because it is easy.
上記検討の結果、本発明の課題を解決するためには、たとえばEGCgを特異的に加水分解しEGCの含有量を増大させるためには、EGCgの特異的かつ安定な加水分解が必要であるという考えに至った。
カテキン類のガレート基の特異的かつ安定な加水分解を求めて検討を重ねた結果、本発明者らは以下のことを見出した。
As a result of the above studies, in order to solve the problems of the present invention, for example, in order to specifically hydrolyze EGCg and increase the content of EGC, specific and stable hydrolysis of EGCg is necessary. I came up with an idea.
As a result of repeated investigations for specific and stable hydrolysis of the gallate group of catechins, the present inventors have found the following.
(1)茶葉(Tea sinensisの葉)はその含有成分であるカテキンにより抗菌性を有しており、そのため、他の穀物(大豆や米)を製麹するときに頻繁に現れ腐敗の原因となる納豆菌やミクロコッカス属等の汚染菌類は、茶葉を製麹するときにはカテキン類による生育阻害を受け、茶葉でまったく繁殖しないのに対し、真菌類は茶葉で繁殖可能であることを見出した。
(2)真菌類の培養に用いる茶葉は、Tea sinensisの葉を所定の水分を含有するように調整したもので、Tea sinensisの生葉からの調整法については殺青の有無、揉捻の有無については問わないが、所定の水分を含有するように調整した茶葉を用いることにより、真菌類の良好かつ優先的な繁殖が可能になることを見出した。すなわち、これらの茶葉は、重量に対する容積比が大きいため、茶葉の水分が適度に分散し、その結果、荒茶において真菌類の良好な繁殖が可能になることを見出した。また、水分量を制限することにより、乾燥に比較的強い真菌類のみが優先的に繁殖可能であることを見出した。
(3)茶葉において真菌類を繁殖させると、真菌類は、茶葉中に豊富に含まれるEGCgをEGCに加水分解するが、EGCの更なる分解を引き起こしにくいため、茶葉中に本来微量しか含まれないが薬理効果が期待されるEGCの含有量を特異的に増大させることができることを見出した。
(1) Tea leaves (Tea sinensis leaves) have antibacterial properties due to their catechins, and therefore appear frequently when other grains (soybeans and rice) are made and cause rot. It was found that contaminating fungi such as Bacillus natto and Micrococcus were inhibited by catechins when brewing tea leaves and did not propagate at all in tea leaves, whereas fungi could be propagated in tea leaves.
(2) The tea leaves used for fungal culture are tea sinensis leaves that have been adjusted to contain the prescribed moisture content. However, the present inventors have found that fungi can be favorably and preferentially propagated by using tea leaves adjusted to contain predetermined moisture. That is, since these tea leaves have a large volume ratio with respect to weight, the water content of the tea leaves is appropriately dispersed, and as a result, it has been found that fungi can be propagated well in crude tea. In addition, by limiting the amount of water, it has been found that only fungi that are relatively resistant to drying can preferentially reproduce.
(3) When fungi are propagated in tea leaves, fungi hydrolyze EGCg abundantly contained in tea leaves into EGC, but it is difficult to cause further degradation of EGC, so that only a small amount is inherently contained in tea leaves. It has been found that the content of EGC, which is not expected to have a pharmacological effect, can be specifically increased.
このように、特定の条件下において茶葉中で真菌類が生育可能であること、並びに茶葉中のカテキン類の成分変化が起こることを見出したことにより、本発明を完成させるに至った。すなわち本発明は、以下の手段を提供する。 Thus, the present invention has been completed by finding that fungi can grow in tea leaves under specific conditions, and that catechins in tea leaves change in components. That is, the present invention provides the following means.
[1]原料の茶葉を、25〜80重量%の水分を含むように調整し、真菌類の作用により発酵させ、次いで加熱乾燥させる工程を含む、茶葉中のカテキン類の含有量比を変化させる方法。
[2]原料の茶抽出物を、50重量%以上の水分が存在する条件下で真菌類の作用により発酵させる工程を含む、茶抽出物中のカテキン類の含有量比を変化させる方法。
[3]前記原料の茶葉を、20重量%以下の糖質を含む条件下で真菌類により発酵させることを特徴とする、[1]に記載の方法。
[4]前記原料の茶抽出物を、20重量%以下の糖質を含む条件下で真菌類により発酵させることを特徴とする、[2]に記載の方法。
[5]前記真菌類が、Saccharomyces cerevisiaeまたはAspergillus oryzaeであることを特徴とする、[1]または[3]に記載の方法。
[6]前記真菌類が、Saccharomyces cerevisiaeまたはAspergillus oryzaeであることを特徴とする、[2]または[4]に記載の方法。
[1] The content ratio of catechins in tea leaves is changed, including the steps of adjusting the raw tea leaves to contain water of 25 to 80% by weight, fermenting them by the action of fungi, and then heating and drying them Method.
[2] A method for changing the content ratio of catechins in a tea extract, comprising a step of fermenting a tea extract as a raw material by the action of fungi under a condition where water of 50% by weight or more exists.
[3] The method according to [1], wherein the raw tea leaves are fermented with fungi under conditions containing 20% by weight or less of sugar.
[4] The method according to [2], wherein the tea extract of the raw material is fermented with fungi under conditions containing 20% by weight or less of a saccharide.
[5] The method according to [1] or [3], wherein the fungus is Saccharomyces cerevisiae or Aspergillus oryzae.
[6] The method according to [2] or [4], wherein the fungus is Saccharomyces cerevisiae or Aspergillus oryzae.
本発明の方法によれば、茶において薬理効果が期待される特定の微量のカテキン成分、たとえばEGCの含有量を増大させ、茶葉または茶抽出物におけるカテキン類の含有量比を変化させることができる。 According to the method of the present invention, it is possible to increase the content of a specific trace amount of catechin components expected to have a pharmacological effect in tea, such as EGC, and to change the content ratio of catechins in tea leaves or tea extracts. .
本発明の方法の一態様によれば、真菌類の一つであるパン酵母(Saccharomyces cerevisiae)は、茶葉におけるEGCgおよびECgのガレート基部分を加水分解し、それぞれEGCおよびECに変換し、EGCおよびECの更なる分解が顕著でないため、茶葉におけるEGCおよびECの含有量を増大させることができる。これにより、茶葉におけるEGCおよびECの機能(前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用)を増強することができる。 According to one embodiment of the method of the present invention, one of the fungi, baker's yeast (Saccharomyces cerevisiae) hydrolyzes the gallate group of EGCg and ECg in tea leaves to convert them to EGC and EC, respectively. Since further degradation of EC is not significant, the EGC and EC content in tea leaves can be increased. Thereby, the functions of EGC and EC in tea leaves (the action of suppressing the accumulation of lipid droplets in preadipocytes and the action of suppressing the expression of PPARγ and C / EBPα) can be enhanced.
また、本発明の方法の別の態様によれば、真菌類の一つである麹菌(Aspergillus oryzae)は、茶葉におけるEGCgおよびECgのガレート基部分を加水分解し、それぞれEGCおよびECに変換し、更にECの方を選択的に分解するため、茶葉におけるEGCの含有量を増大させることができる。EGCはECに比べて、前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用が高いだけではなく、抗酸化能力も約3倍高い。このため、麹菌を使用した場合には、発酵時間によってはEC含有量の減少を伴う場合があるが、EGC含有量の増大により、前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用が増強され、抗酸化効果についても大きな減少を伴わない。さらに、EGCやEC等の加水分解体は、EGCgやECg等のガレート体に比べて渋味が少なく、また、EGCとECの渋味はほぼ同等であることより、麹菌を使用した場合には、ECの減少により抗酸化効果の大きな減少を伴わずに渋味を軽減させることができるという利点も有する。 According to another aspect of the method of the present invention, Aspergillus oryzae, one of the fungi, hydrolyzes the gallate group portion of EGCg and ECg in tea leaves, and converts them into EGC and EC, respectively. Furthermore, since EC is selectively decomposed, the content of EGC in tea leaves can be increased. Compared with EC, EGC not only has an action of suppressing the accumulation of lipid droplets in preadipocytes and an action of suppressing the expression of PPARγ and C / EBPα, but also has an antioxidant capacity about 3 times higher. For this reason, when Neisseria gonorrhoeae is used, it may be accompanied by a decrease in EC content depending on fermentation time. Is suppressed, and the antioxidant effect is not significantly reduced. Furthermore, hydrolysates such as EGC and EC have less astringency than gallate bodies such as EGCg and ECg, and the astringency of EGC and EC is almost the same. Further, there is an advantage that astringency can be reduced without greatly reducing the antioxidant effect due to the decrease in EC.
本発明の方法に従って、茶葉に代えて茶抽出物を発酵させた場合も、同様の効果が得られる。 Similar effects can be obtained when the tea extract is fermented instead of tea leaves according to the method of the present invention.
(1)茶葉におけるカテキン類の含有量比を変化させる方法
以下、茶葉におけるカテキン類の含有量比を変化させる方法について詳細に説明する。
本発明の方法において使用される原料の茶葉は、不発酵茶、発酵茶、半発酵茶の何れも使用可能である。不発酵茶は、茶の葉を殺青後、揉みながら乾燥させるため、荒茶を25〜80重量%の水分を含むように調整してもよいし、あるいは、荒茶を製造する途中の茶葉(すなわち、青殺後の茶葉、粗揉後の茶葉、揉捻後の茶葉、中揉後の茶葉、精揉後の茶葉)を、25〜80重量%の水分を含むように調整してもよい。ここで原料の茶葉が、「青殺後の茶葉、粗揉後の茶葉、揉捻後の茶葉、中揉後の茶葉」など、総重量に対して25〜80重量%の水分を既に含んでいる場合、それを水分調整することなくそのまま使用してもよい。また、原料の茶葉が「精揉後の茶葉または荒茶」である場合一般に、水分を加えることにより所定の水分を含むように調整する。本発明では、好ましくは荒茶を原料として使用することができる。また、殺青工程がない発酵茶や殺青工程が遅い半発酵茶も、その水分含量を調整することにより、その製品や製造工程中のものを原料として使用可することができる。
(1) Method of changing content ratio of catechins in tea leaves Hereinafter, a method of changing the content ratio of catechins in tea leaves will be described in detail.
The raw tea leaves used in the method of the present invention can be any of non-fermented tea, fermented tea, and semi-fermented tea. Since unfermented tea is dried while it is teased after killing the tea leaves, the crude tea may be adjusted to contain 25 to 80% by weight of water, or the tea leaves ( That is, the tea leaves after blue killing, the tea leaves after coarse koji, the tea leaves after twisting, the tea leaves after churn, and the tea leaves after sperm may be adjusted to contain 25 to 80% by weight of water. Here, the raw tea leaves already contain 25 to 80% by weight of water, such as “tea leaves after killing, tea leaves after rough culm, tea leaves after twisting, and tea leaves after churn”. In this case, it may be used as it is without adjusting moisture. In addition, when the raw tea leaves are “tea leaves after rough brewing or rough tea”, in general, adjustment is made to include predetermined moisture by adding moisture. In the present invention, it is preferable to use crude tea as a raw material. In addition, fermented tea that does not have a blue-killing process and semi-fermented tea that has a slow blue-killing process can be used as a raw material by adjusting its water content.
茶葉の水分調整について、「荒茶」を使用した場合を例に以下説明する。「荒茶」は、約3〜5重量%の水分を既に含んでいる。よって、加える水分量は、茶葉が含んでいる水分を考慮して調整する必要がある。例えば、5重量%の水分を含む「原料の荒茶」1kgに、357mLの水を加えることにより、「約30重量%の水分を含むように調整された荒茶」が得られる。あるいは、「25〜80重量%の水分を含むように調整された茶葉」は、乾燥時間を短縮し、所望の水分含量まで乾燥させることにより調製することも可能である。 The adjustment of the moisture content of tea leaves will be described below using an example of “rough tea”. “Rough tea” already contains about 3 to 5% by weight of water. Therefore, the amount of water to be added needs to be adjusted in consideration of the water contained in the tea leaves. For example, by adding 357 mL of water to 1 kg of “raw raw tea” containing 5% by weight of water, “crude tea adjusted to contain about 30% by weight of water” can be obtained. Alternatively, “tea leaves adjusted to contain 25 to 80% by weight of water” can be prepared by shortening the drying time and drying to a desired water content.
ここで水分含量は、発酵に用いる真菌類が繁殖、発酵可能な量であり、低水分含量から高水分含量まで広い範囲で可能であるが、好ましくは後の乾燥工程を簡便にするため低い水分含量に設定される。低い水分含量は、後の乾燥工程を簡便にすることができるとともに、乾燥に比較的強い真菌類を優先的に繁殖させるので、雑菌汚染を防止することができる。本発明では、比較的低い水分含量で真菌類が繁殖、発酵可能であることが判ったため、「25〜80重量%の水分を含むように調整された茶葉」が使用され、好ましくは「25〜50重量%の水分を含むように調整された茶葉」、より好ましくは「30〜35重量%の水分を含むように調整された茶葉」が使用される。 Here, the water content is the amount that the fungi used for fermentation can propagate and ferment, and can be in a wide range from low water content to high water content, but preferably low water content to simplify the subsequent drying process. Set to content. The low moisture content can simplify the subsequent drying process and can preferentially propagate fungi that are relatively resistant to drying, thereby preventing contamination with various bacteria. In the present invention, it has been found that fungi can propagate and ferment at a relatively low water content. Therefore, “tea leaves adjusted to contain 25 to 80% by weight of water” are used, preferably “25 to 25%. “Tea leaves adjusted to contain 50% by weight of water”, more preferably “tea leaves adjusted to contain 30 to 35% by weight of water” are used.
本発明において摘栽後の中間品の茶葉以外に、「荒茶」を使用する理由は、(1)原料として長時間貯蔵できること、(2)褐変酵素など不要な酵素類を含まないこと、(3)茶葉の重量に対する容積比が大きいため、水分を茶葉に適度に分散させることができ、このことが真菌類の繁殖に適していることを本発明者らが見出したためである。 In addition to the intermediate tea leaves after pruning in the present invention, the reason for using `` raw tea '' is (1) that it can be stored for a long time as a raw material, (2) it does not contain unnecessary enzymes such as browning enzymes, 3) Since the volume ratio with respect to the weight of tea leaves is large, the present inventors have found that water can be appropriately dispersed in tea leaves, which is suitable for fungal growth.
本発明において使用可能な真菌類は、茶に含まれるカテキン類の含有量比を変化させ、所望のカテキン成分を特異的に増大させることが可能な菌株であれば特に限定されず、たとえば、EGCgおよびECgのガレート基を加水分解し、EGC含有量を増大させることが可能な菌株であれば特に限定されない。 The fungus usable in the present invention is not particularly limited as long as it is a strain that can change the content ratio of catechins contained in tea and specifically increase a desired catechin component. For example, EGCg As long as the strain can hydrolyze the gallate group of ECg and increase the EGC content, it is not particularly limited.
本発明で使用可能な真菌類としては、主としてSaccharomyces属、Aspergillus属の菌株が挙げられるが、Schizosaccharomyces属、Candida属、Torulopsis属、Mycotorula属、Oidium属、Debariomyces属、Phaffia属、Aureobasidium属、Eurotium属、Mucor属、Monascus属、Pleurotus属、Armillaria属、Lentinus属、Ganoderma属、Pholiota属、Flammulina属、Agaricus属、Grifola属、Schizophyllum属の菌株も使用可能である。より具体的には、Saccharomyces cerevisiae、S. carlsbergensis、S. rouxii、Baker’’s yeast、Wine yeast、Aspergillus oryzae、A. usamii、A. sirousamii、A. niger、A. kawachi、A. awamori、A. sojae、Schizosaccharomyces pombe、Candida utilis、C. tropicalis、Torulopsis utilis、T. pulcherima、Mycotorula japonica、Oidium lactis、Debariomyces hansenii、Phaffia rhodozyma、Aureobasidium pullulans、Eurotium repens、Mucor rouxii、Monascus anka、M. purpureus、Pleurotus ostreatus、Armillaria mellea、Lentinus edodes、Ganoderma lucidum、Pholiota nameko、Flammulina velutipes、Agaricus blazei Murill、A. bisporus、Grifola frondosa、Schizophyllum communeが挙げられる。これら菌株は、IFO、IAM、ATCC、NRRC等の菌株分譲機関、日本醸造協会(清酒酵母等)や市販の種菌株販売会社、例えば、株式会社菱六(種麹販売)、森産業株式会社(きのこの種菌販売)等から入手可能である。 Examples of fungi that can be used in the present invention include strains of the genus Saccharomyces and Aspergillus. Strains of the genus Mucor, Monascus, Pleurotus, Armillaria, Lentinus, Ganoderma, Pholiota, Flammulina, Agaricus, Grifola, and Schizophyllum can also be used. More specifically, Saccharomyces cerevisiae, S. carlsbergensis, S. rouxii, Baker ''s yeast, Wine yeast, Aspergillus oryzae, A. usamii, A. sirousamii, A. niger, A. kawachi, A. awamori, A sojae, Schizosaccharomyces pombe, Candida utilis, C. tropicalis, Torulopsis utilis, T. pulcherima, Mycotorula japonica, Oidium lactis, Debariomyces hansenii, Phaffia rhodozyma, Aureobasidium pullulans, Eurotium repens, Eurocium repens, Eurotium repens, , Armillaria mellea, Lentinus edodes, Ganoderma lucidum, Pholiota nameko, Flammulina velutipes, Agaricus blazei Murill, A. bisporus, Grifola frondosa, Schizophyllum commune. These strains include strain distribution agencies such as IFO, IAM, ATCC, NRRC, Japan Brewing Association (sake yeast, etc.) and commercial seed strain sales companies such as Rishoku Co., Ltd. It is available from mushroom inoculum sales).
上記列記した真菌は、茶葉のカテキン類を立体特異的に分解するという性質、およびカテキン類の種類により分解スピードが異なるという性質を有する。そのため、その分解スピードの違いを利用して、茶葉の特定のカテキン成分の含有量を増大させることができる。 The fungi listed above have the property of degrading catechins of tea leaves in a stereospecific manner and the property of degrading speed depending on the type of catechins. Therefore, the content of specific catechin components in tea leaves can be increased by utilizing the difference in decomposition speed.
具体的には、カテキン類のガレート基の加水分解は、すべての真菌においてカテキン類の立体構造を維持したまま行われる。すなわち、茶に含まれるEGCgはEGCに加水分解され、ECgはECに加水分解される。しかし、ECよりも抗酸化活性が高いEGCは、真菌によるその後の分解を受けにくい。そのため、上記真菌を使用して茶葉の発酵を行うことにより、抗酸化活性が高いEGCの含有量を特異的に増大させることができる。 Specifically, hydrolysis of the gallate group of catechins is performed while maintaining the three-dimensional structure of catechins in all fungi. That is, EGCg contained in tea is hydrolyzed to EGC, and ECg is hydrolyzed to EC. However, EGC, which has higher antioxidant activity than EC, is less susceptible to subsequent degradation by fungi. Therefore, content of EGC with high antioxidant activity can be specifically increased by performing fermentation of tea leaves using the above fungi.
EGCは、上述のとおりEGCgとは異なり、前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用を有することが報告されている。したがって、EGCの含有量を特異的に増大させることにより、本来茶葉に少量しか含まれないEGCの機能を特異的に増強することができる。 As described above, EGC has been reported to have an action of suppressing the accumulation of lipid droplets of preadipocytes and an action of suppressing the expression of PPARγ and C / EBPα, unlike EGCg. Therefore, by specifically increasing the EGC content, it is possible to specifically enhance the function of EGC, which is originally contained in a small amount in tea leaves.
ただし、真菌の種類によって、EGCgのガレート基を加水分解してEGCに変換し、更にEGCを分解する能力に差がある。したがって、特定の真菌を用いてEGCの含量を増大させる場合、「EGCgをEGCに加水分解するが、更にEGCを分解しないか、またはEGCの分解能力が低い真菌」を選択するか、あるいは「EGCgがEGCに変換されているが、更なるEGCの分解に至っていない発酵期間」を予め設定することが望ましい。「EGCgをEGCに加水分解するが、更にEGCを分解しないか、またはEGCの分解能力が低い真菌」としては、Saccharomyces cerevisiaeを挙げることができる。また、真菌としてAspergillus oryzaeを使用した場合、「EGCgがEGCに変換されているが、更なるEGCの分解に至っていない発酵期間」として、発酵条件にもよるが、1日〜14日の発酵期間を設定することができる。上述のとおり本発明では、EGCgをEGCに変換する能力を有するが、EGCの分解能力を有していないかまたは低い特定の真菌を用いてEGCの含量を増大させることが可能であり、このような真菌は、本発明において好ましいものとして使用することができる。 However, depending on the type of fungus, the ability to hydrolyze the EGCg gallate group into EGC and further decompose EGC is different. Therefore, when increasing the content of EGC using a specific fungus, select “a fungus that hydrolyzes EGCg to EGC but does not further degrade EGC, or has a low ability to degrade EGC” or “EGCg It is desirable to set in advance a “fermentation period in which is converted to EGC but has not yet been further decomposed by EGC”. Examples of the fungus that hydrolyzes EGCg to EGC but does not further degrade EGC or has a low ability to degrade EGC include Saccharomyces cerevisiae. In addition, when Aspergillus oryzae is used as a fungus, the fermentation period of 1 to 14 days depends on the fermentation conditions as “fermentation period in which EGCg is converted to EGC but has not led to further degradation of EGC”. Can be set. As described above, in the present invention, it is possible to increase the content of EGC using a specific fungus that has the ability to convert EGCg to EGC but does not have the ability to degrade EGC, or is low. Can be used as preferred in the present invention.
本発明において発酵は、上述のとおり水分含量を調製した茶葉に上記真菌類を接種し、一般に20〜50℃、好ましくは20〜40℃で1〜10日間、真菌類を繁殖させることにより行うことができる。 In the present invention, fermentation is performed by inoculating the above-mentioned fungi on the tea leaves whose water content has been adjusted as described above, and generally allowing the fungi to propagate at 20-50 ° C, preferably 20-40 ° C for 1-10 days. Can do.
本発明の好ましい態様において、茶葉を発酵する際、発酵の条件下に任意の糖質、好ましくは単糖類または二糖類、例えば砂糖、果糖、ブドウ糖、麦芽糖または蜂蜜を添加することができる。すなわち、真菌類は生育に糖質が必要なものもあれば必要ないものもあるため、発酵の際に菌類によっては0〜20重量%(最終濃度)の範囲で糖質を添加しておくことが望ましいものもある。たとえば、真菌類としてSaccharomyces cerevisiaeを用いた場合、発酵の際に糖質を添加しておくことが望ましい。なお、糖質の含量が、総重量に対して50重量%以上になると、どのような菌種でもその生育が抑制されるため好ましくない。 In a preferred embodiment of the present invention, when fermenting tea leaves, any sugars, preferably monosaccharides or disaccharides such as sugar, fructose, glucose, maltose or honey can be added under the conditions of fermentation. That is, some fungi may need sugar for growth, and some do not need it, so depending on the fungus, add sugar in the range of 0 to 20% by weight (final concentration). Some are desirable. For example, when Saccharomyces cerevisiae is used as a fungus, it is desirable to add a carbohydrate during fermentation. In addition, it is not preferable that the saccharide content is 50% by weight or more with respect to the total weight because growth of any microbial species is suppressed.
糖質を添加して、真菌類による茶葉の発酵を行うと、真菌類の生育が良好になると同時に発酵が促進され、エタノール生成が顕著になる場合が多く、官能評価で更に良好な結果が得られる。これは、エタノールのエステル類が生成したためと思われる。 Fermentation of tea leaves with fungi by adding saccharides promotes fungal growth and at the same time promotes fermentation, and ethanol production is often prominent. It is done. This is probably due to the formation of ethanol esters.
真菌類による発酵工程を経た茶葉は、80〜120℃で加熱乾燥し、真菌類を殺菌するとともに、水分含量を5重量%以下(一般に3〜5重量%)に減らす。これにより、常温での保管が可能であり、かつ特定のカテキン類の増大した機能性の高い発酵茶が製造される。このように本発明により得られる発酵茶は、特定のカテキン類が増大し、その機能性において優れているだけでなく、後述の実施例で示されるとおり官能評価においてもよい結果を示すものである。 Tea leaves that have undergone the fermentation process with fungi are heat-dried at 80 to 120 ° C. to sterilize the fungi and reduce the water content to 5 wt% or less (generally 3 to 5 wt%). As a result, a highly functional fermented tea that can be stored at room temperature and has increased specific catechins is produced. As described above, the fermented tea obtained according to the present invention not only excels in specific catechins and is excellent in functionality, but also shows good results in sensory evaluation as shown in Examples described later. .
(2)茶抽出物におけるカテキン類の含有量比を変化させる方法
茶抽出物におけるカテキン類の含有量比を変化させる方法は、上述の茶葉における方法と同様にして行うことができる。よって、上述の茶葉における方法と異なる点のみ以下で説明する。
(2) Method of changing the content ratio of catechins in the tea extract The method of changing the content ratio of catechins in the tea extract can be performed in the same manner as in the above-described method of tea leaves. Therefore, only the differences from the method for tea leaves described above will be described below.
原料の茶抽出物としては、茶葉を温水等の溶剤で抽出することにより得られた茶抽出液、あるいは茶葉を温水等の溶剤で抽出し、その抽出液を賦形剤等と共にスプレードライ乾燥させた茶抽出乾燥物など、任意の茶抽出物を使用することができる。例えば市販のインスタントティーの抽出液、市販の茶抽出乾燥物、サンフェノン(太陽化学製)などを使用することができる。 As a tea extract as a raw material, a tea extract obtained by extracting tea leaves with a solvent such as warm water, or a tea leaf is extracted with a solvent such as warm water, and the extract is spray-dried together with excipients and the like. Any tea extract such as dried tea extract can be used. For example, a commercially available instant tea extract, a commercially available dried tea extract, or Sanphenon (manufactured by Taiyo Kagaku) can be used.
本方法では、原料の茶抽出物を、真菌類が生育可能な水分が存在する条件下で真菌類の作用により発酵させるが、この条件は、茶抽出物として茶抽出液を使用した場合には、水を添加しなくてもよいが、50重量%以上、好ましくは50〜95重量%、より好ましくは70〜95重量%の水分を最終濃度で含むように水を添加してもよい。あるいは、茶抽出物として茶抽出乾燥物を使用した場合には、50重量%以上、好ましくは50〜95重量%、より好ましくは70〜95重量%の水分を最終濃度で含むように水を添加する。 In this method, the tea extract as a raw material is fermented by the action of fungi in the presence of moisture that allows fungi to grow. This condition is used when a tea extract is used as the tea extract. Water may not be added, but water may be added so as to contain 50% by weight or more, preferably 50 to 95% by weight, more preferably 70 to 95% by weight of water at a final concentration. Alternatively, when a tea extract dried product is used as the tea extract, water is added so as to contain 50% by weight or more, preferably 50 to 95% by weight, more preferably 70 to 95% by weight of water at the final concentration. To do.
本方法でも、糖質を添加して真菌類による発酵を行うと、真菌類の生育が良好になると同時に発酵が促進されるため、上記条件に糖質を添加することが好ましい。糖質を添加する濃度としては、最終濃度で0〜20重量%とすることができる。後述の実施例3のように、糖質として、糖を主成分とする麦芽エキスを添加してもよい。 Also in this method, if a saccharide is added and fermentation is performed with fungi, the growth of the fungus is improved and at the same time the fermentation is promoted. Therefore, it is preferable to add the saccharide under the above conditions. The concentration of the saccharide added can be 0 to 20% by weight in the final concentration. As in Example 3 described later, a malt extract containing sugar as a main component may be added as a saccharide.
発酵工程を終えた茶抽出物は、殺菌後、乾燥し、常温での保管が可能な形態とすることができるが、このとき、シクロデキストリン等の乾燥補助剤を添加してもよい。 The tea extract that has been subjected to the fermentation process can be dried after sterilization and can be stored at room temperature. At this time, a drying aid such as cyclodextrin may be added.
また本発明は、別の側面によれば、
(1)原料の茶葉を、25〜80重量%の水分を含むように調整し、真菌類の作用により発酵させ、次いで加熱乾燥させる工程を含む、カテキン類の含有量比を変化させた茶葉の製造方法、並びに
(2)原料の茶抽出物を、50重量%以上の水分が存在する条件下で真菌類の作用により発酵させる工程を含む、カテキン類の含有量比を変化させた茶抽出物の製造方法
に関する。
上記(1)および(2)の方法に従って、カテキン類の含有量比が変化した発酵茶および発酵茶抽出物が提供される。
According to another aspect of the present invention,
(1) A tea leaf with a changed content ratio of catechins, comprising a step of adjusting the raw tea leaves to contain water of 25 to 80% by weight, fermenting them by the action of fungi, and then heating and drying them Production method, and (2) Tea extract in which the content ratio of catechins is changed, comprising the step of fermenting the tea extract as a raw material by the action of fungi under conditions where water of 50% by weight or more is present It relates to the manufacturing method.
According to the methods (1) and (2) above, fermented tea and fermented tea extract in which the content ratio of catechins is changed are provided.
また、本発明の方法に従って、茶に含まれるカテキン類の含有量比をコントロールし、特定のカテキン成分、たとえばEGCを増大させることにより、EGCの有する機能(すなわち、糖尿病誘発抑制および前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用)を増強することができる。したがって、本発明によれば、
上記(1)の方法により製造された発酵茶または上記(2)の方法により製造された発酵茶抽出物を活性成分として含有する血糖上昇抑制剤、並びに
上記(1)の方法により製造された発酵茶または上記(2)の方法により製造された発酵茶抽出物を活性成分として含有する体脂肪蓄積抑制剤
が提供される。
In addition, according to the method of the present invention, by controlling the content ratio of catechins contained in tea and increasing a specific catechin component, for example, EGC, the functions of EGC (that is, suppression of diabetes induction and preadipocytes) It is possible to enhance the lipid droplet accumulation suppressing action and the PPARγ and C / EBPα expression suppressing action. Therefore, according to the present invention,
A blood sugar elevation inhibitor containing as an active ingredient a fermented tea produced by the method (1) or a fermented tea extract produced by the method (2), and a fermentation produced by the method (1) There is provided a body fat accumulation inhibitor containing tea or a fermented tea extract produced by the method of (2) as an active ingredient.
[実施例1]
緑茶(Tea sinensisの葉を殺青し揉みながら乾燥したもの)3 kgと、水1 Lに砂糖(大日本製糖)150 gを溶かした溶液(1.15 kg)とを混合し、28重量%の水分と3.6重量%の砂糖を含む「発酵茶原料」を調製した。これに、ドライイースト(日清製粉、商品名カメリア)1 gを接種し、10 Lのステンレス容器に入れ、静置培養において30℃で6日間発酵させた。その後、乾燥機温度が120℃で茶温が90℃に到達した後10分加熱乾燥し、「発酵茶」を調製した。カテキン類については液体クロマトグラフ法(広瀬真一他 茶業研究報告 50 51 (1979))で分析し、香味については5人のパネラーが茶葉2 gの熱湯100 mL抽出液を官能審査することにより評価した。
[Example 1]
Mix 3 kg of green tea (Tea sinensis leaves that have been killed and dried) and 1 liter of water with 150 g of sugar (Dai Nippon sugar) dissolved in 1.15 kg. A “fermented tea raw material” containing 3.6% by weight of sugar was prepared. This was inoculated with 1 g of dry yeast (Nisshin Flour Milling, trade name Camellia), placed in a 10 L stainless steel container, and fermented at 30 ° C. for 6 days in static culture. Then, after the dryer temperature was 120 ° C. and the tea temperature reached 90 ° C., it was dried by heating for 10 minutes to prepare “fermented tea”. The catechins were analyzed by liquid chromatography (Shinichi Hirose et al. Tea Industry Research Report 50 51 (1979)), and the flavor was evaluated by sensory examination of 100 mL hot water extract of 2 g tea leaves by 5 panelists. did.
カテキン類の含量の変化を表1に示し、官能検査結果を表2に示す。
酵母で発酵処理した茶葉において、EGCgとEGCの総和(EGCg+EGC)がほとんど変化していないにもかかわらず、EGCgが減少し、EGCが増加している。また、ECgとECの総和(ECg+EC)がほとんど変化していないにもかかわらず、ECgが減少し、ECが増加している。以上より、EGCgおよびECgは、これらのガレート基が加水分解され、それぞれEGCおよびECに定量的に変換されたことがわかる。また表2の結果より、「発酵茶」の香味が、発酵処理していない茶葉の抽出液と比べてまろやかになっていることがわかる。 In tea leaves fermented with yeast, EGCg decreases and EGC increases even though the sum of EGCg and EGC (EGCg + EGC) hardly changes. In addition, although the sum of ECg and EC (ECg + EC) has hardly changed, ECg has decreased and EC has increased. From the above, it can be seen that EGCg and ECg were quantitatively converted to EGC and EC, respectively, by hydrolysis of these gallate groups. Moreover, it turns out that the flavor of "fermented tea" is mellow compared with the extract of the tea leaf which is not fermented from the result of Table 2.
[実施例2]
緑茶(Tea sinensisの葉を殺青し揉みながら乾燥したもの)3 kgと水1 Lを混合し、実施例1と同様にして、28重量%の水分と3.6重量%の砂糖を含む「発酵茶原料」を調製した。これに、焼酎用の種麹A.kawachi HS-185、白味噌用の種麹A.oryzae HW-08、赤味噌用の種麹A.oryzea HF-101(いずれも株式会社菱六より入手)のいずれか1 gを接種し、10 Lのステンレス容器に入れ、静置培養において30〜40℃で6日間発酵させた。その後、乾燥機温度が120℃で茶温が90℃に到達した後10分加熱乾燥し、「発酵茶」を調製した。加えて、赤味噌用の麹菌A.oryzea HF101については発酵が早いため、2日間発酵した後、加熱乾燥したものも調製した。カテキン類については液体クロマトグラフ法で分析し、香味については5人のパネラーが茶葉2 gの熱湯100 mL抽出液を官能審査することにより評価した。
[Example 2]
Mix 3 kg of green tea (Tea sinensis leaves, dried with mastication) and 1 L of water, and in the same way as in Example 1, "Fermented tea ingredients containing 28% water and 3.6% sugar" Was prepared. This includes A.kawachi HS-185 for shochu, A.oryzae HW-08 for white miso, A.oryzea HF-101 for red miso (all from Hiroku Corporation) Was inoculated, placed in a 10 L stainless steel container, and fermented at 30 to 40 ° C. for 6 days in a stationary culture. Then, after the dryer temperature was 120 ° C. and the tea temperature reached 90 ° C., it was dried by heating for 10 minutes to prepare “fermented tea”. In addition, the A. oryzea HF101 for red miso was fermented quickly, so that it was also fermented for 2 days and then dried by heating. The catechins were analyzed by liquid chromatography, and the flavor was evaluated by a sensory examination of 5 panelists of 2 g tea leaf hot water extract by 5 panelists.
カテキン類の含量の変化を表3に示し、官能検査結果を表4に示す。
焼酎用麹および白味噌用麹で発酵処理した茶葉においては、EGCgとEGCの総和(EGCg+EGC)がほとんど変化していないにもかかわらず、EGCgが減少し、EGCが増加している。一方、これら「発酵茶」のECgとECの総和(ECg+EC)には減少が認められる。以上より、焼酎用麹および白味噌用麹で発酵処理した茶葉では、EGCgはそのガレート基が加水分解されEGCに定量的に変換されるが、ECgはそのガレート基が加水分解された後、更にEC自体が分解されていることが示唆された。その結果として、これら「発酵茶」の香味がまろやかになっている(渋味が軽減している)ことが表4の結果からも示される。つまり、焼酎用麹および白味噌用麹で茶葉を発酵処理すると、ECが選択的に分解され、抗酸化活性の高いEGCだけが残ることにより、渋味が軽減され、かつ抗酸化活性の高い茶ができると考えられる。また、EGCは他のカテキン類よりも、糖尿病誘発抑制および前駆脂肪細胞の脂肪滴の蓄積抑制作用やPPARγやC/EBPαの発現抑制作用が強いと報告されているため、得られた「発酵茶」は、肥満、糖尿病等に有効であることが期待される。 In tea leaves fermented with shochu lees and white miso lees, EGCg decreased and EGC increased even though the sum of EGCg and EGC (EGCg + EGC) hardly changed. On the other hand, the ECg and EC total (ECg + EC) of these “fermented teas” are reduced. From the above, in tea leaves fermented with shochu lees and white miso lees, EGCg is quantitatively converted to EGC by hydrolysis of its gallate group, but ECg is further converted after hydrolysis of its gallate group. It was suggested that EC itself was decomposed. As a result, it is also shown from the results in Table 4 that the flavor of these “fermented teas” is mellow (astringency is reduced). In other words, when tea leaves are fermented with shochu lees and white miso lees, EC is selectively decomposed, leaving only EGC with high antioxidant activity, thereby reducing astringency and having high antioxidant activity. It is thought that you can. In addition, EGC has been reported to have a stronger effect of inhibiting the induction of diabetes, an accumulation of lipid droplets of preadipocytes, and an effect of suppressing the expression of PPARγ and C / EBPα than other catechins. "Is expected to be effective for obesity, diabetes and the like.
一方、赤味噌用麹で発酵処理した茶葉においては、EGCgとEGCの総和(EGCg+EGC)、ECgとECの総和(ECg+EC)ともに減少が認められる。つまり、EGCgやECgのガレート基が分解されるとともに、EGCおよびECの両方が分解されていることが示唆された。ただし、ECgとECの総和が0.1と低いという結果に着目すると、赤味噌用麹も、ECの分解がEGCの分解に比べて優先的であることがわかる。したがって、赤味噌用麹による発酵時間を短くする(本実施例では6日間から2日間に短縮する)ことにより、EGCの含量を増大させる(本実施例では1.1重量%から2.0重量%へと増大させる)ことができる。このように、赤味噌用麹による発酵においてもECを減少させ、EGCを増大させる発酵時間を選択することにより、渋味が軽減され、かつ抗酸化活性の高い茶ができると考えられる。また、EGCは他のカテキン類よりも脂肪細胞の分化抑制作用やPPARγの発現抑制が強いと報告されているため、得られた「発酵茶」は、肥満、糖尿病等に有効であることが期待される。 On the other hand, in tea leaves fermented with red miso koji, a decrease was observed in both the sum of EGCg and EGC (EGCg + EGC) and the sum of ECg and EC (ECg + EC). That is, it was suggested that the gallate group of EGCg and ECg was decomposed and that both EGC and EC were decomposed. However, paying attention to the result that the sum of ECg and EC is as low as 0.1, it can be seen that red miso koji also has a higher priority for EC decomposition than EGC decomposition. Therefore, the EGC content is increased (in this example, from 1.1% to 2.0% by weight) by shortening the fermentation time with the red miso koji (in this example, shortening from 6 days to 2 days). Can). Thus, it is considered that tea can be reduced in astringency and high in antioxidant activity by selecting a fermentation time that reduces EC and increases EGC even in fermentation with red miso koji. In addition, since EGC has been reported to have a stronger effect of inhibiting adipocyte differentiation and PPARγ expression than other catechins, the obtained “fermented tea” is expected to be effective for obesity, diabetes and the like. Is done.
赤味噌用麹のようにカテキン類の分解能力が高いものは、EGC含量の高い発酵茶を調製する際に、発酵時間を短く設定することができる。このように使用する麹菌の種類や発酵時間を変えることにより、カテキン類の含量をコントロールすることが可能である。 When preparing catechins having a high ability to decompose catechins such as red miso koji, fermentation time can be set short when preparing fermented tea having a high EGC content. Thus, it is possible to control the content of catechins by changing the type of koji mold used or the fermentation time.
[実施例3]
水1 Lに麦芽エキス(BACT製)20 gを溶かした溶液(1.02 kg)を混合、加圧殺菌した後、緑茶抽出物(太陽化学製)300 gを添加し、76重量%の水分と2重量%の麦芽エキスを含む「発酵茶抽出物の原料」を調製した。これに、ドライイースト(日清製粉、商品名カメリア)1 gを接種し、2 Lのステンレス容器に入れ、静置培養において30℃で6日間発酵させた。その後、乾燥機温度が120℃で茶温が90℃に到達した後10分加熱乾燥し、「発酵茶抽出物」を調製した。カテキン類については液体クロマトグラフ法で分析した。
[Example 3]
A solution (1.02 kg) of malt extract (BACT) 20 g dissolved in 1 L of water was mixed and pasteurized, then 300 g of green tea extract (Taiyo Kagaku) was added, and 76 wt% water and 2 A “fermented tea extract raw material” containing wt% malt extract was prepared. This was inoculated with 1 g of dry yeast (Nisshin Flour Milling, trade name Camellia), placed in a 2 L stainless steel container, and fermented at 30 ° C. for 6 days in static culture. Then, after the dryer temperature was 120 ° C. and the tea temperature reached 90 ° C., it was dried by heating for 10 minutes to prepare “fermented tea extract”. Catechins were analyzed by liquid chromatography.
カテキン類の含量の変化を表5に示す。
酵母により発酵処理された茶抽出物においては、EGCgとEGCの総和(EGCg+EGC)が、発酵処理していない茶抽出物と比較してほとんど変化することなく、EGCgが減少し、EGCが増加している。また、ECgとECの総和(ECg+EC)もほとんど変化することなく、ECgが減少し、ECが増加している。以上より、EGCgおよびECgは、これらのガレート基が加水分解され、それぞれEGCおよびECに定量的に変換されたことがわかる。EGCは、EGCgと異なり、脂肪細胞の分化抑制作用やPPARγの発現抑制が強いと報告されているため、発酵処理された緑茶抽出物は、肥満、糖尿病等に有効であることが期待される。 In the tea extract fermented with yeast, the total of EGCg and EGC (EGCg + EGC) hardly changed compared to the tea extract not fermented, EGCg decreased, and EGC increased. Yes. Further, ECg and EC total (ECg + EC) hardly change, ECg decreases, and EC increases. From the above, it can be seen that EGCg and ECg were quantitatively converted to EGC and EC, respectively, by hydrolysis of these gallate groups. Unlike EGCg, EGC has been reported to have a strong effect of suppressing differentiation of adipocytes and suppression of PPARγ expression, and therefore, the fermented green tea extract is expected to be effective for obesity, diabetes and the like.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005228631A JP4801948B2 (en) | 2005-08-05 | 2005-08-05 | Method for changing the content ratio of catechins in tea leaves and tea extracts |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005228631A JP4801948B2 (en) | 2005-08-05 | 2005-08-05 | Method for changing the content ratio of catechins in tea leaves and tea extracts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007043907A JP2007043907A (en) | 2007-02-22 |
| JP4801948B2 true JP4801948B2 (en) | 2011-10-26 |
Family
ID=37847316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005228631A Expired - Fee Related JP4801948B2 (en) | 2005-08-05 | 2005-08-05 | Method for changing the content ratio of catechins in tea leaves and tea extracts |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4801948B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20100122296A (en) * | 2009-05-12 | 2010-11-22 | (주)아모레퍼시픽 | Composition containing fermentation tea for improving blood circulation and pharmaceutical composition and health food composition comprising thereof |
| KR101837633B1 (en) * | 2009-06-15 | 2018-03-12 | (주)아모레퍼시픽 | Composition for promotion of alcohol's degradation |
| KR101612724B1 (en) | 2014-01-28 | 2016-04-15 | 재단법인 하동녹차연구소 | method for manufacturing fermenred tea using golden flowering fungi |
| WO2015163062A1 (en) * | 2014-04-23 | 2015-10-29 | 日本製紙株式会社 | Agent for preventing or ameliorating diabetes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4849993A (en) * | 1971-10-23 | 1973-07-14 | ||
| JPS62257343A (en) * | 1986-05-01 | 1987-11-09 | Shikishima Seipan Kk | Treatment of tea leaf |
| JPH04281741A (en) * | 1991-03-08 | 1992-10-07 | Kanebo Ltd | Production of fermented black tea beverage |
| JP3284158B2 (en) * | 1994-07-25 | 2002-05-20 | 天野エンザイム株式会社 | Cordyceps tea and its manufacturing method |
| ATE238683T1 (en) * | 1996-02-14 | 2003-05-15 | Nestle Sa | METHOD FOR PRODUCING A FERMENTED DRINK. |
| JP3929630B2 (en) * | 1998-12-25 | 2007-06-13 | カルピス株式会社 | Acidic beverage with enhanced fruit-like aroma and method for producing the same |
| JP4278566B2 (en) * | 2004-05-28 | 2009-06-17 | 日本サプリメント株式会社 | Fermented tea production method |
| JP2005278519A (en) * | 2004-03-30 | 2005-10-13 | Japan Tobacco Inc | Post-heating fermented tea beverage and method for producing the same |
| JP4459737B2 (en) * | 2004-07-02 | 2010-04-28 | 株式会社福寿園 | Fermented functional tea |
-
2005
- 2005-08-05 JP JP2005228631A patent/JP4801948B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007043907A (en) | 2007-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6186070B2 (en) | MYCELATED COFFEE PRODUCT AND PRODUCTION METHOD | |
| CN108289422B (en) | Method of producing mushrooms | |
| Moon et al. | Conventional and novel applications of edible mushrooms in today's food industry | |
| Naeem et al. | Emerging role of edible mushrooms in food industry and its nutritional and medicinal consequences | |
| JP4459737B2 (en) | Fermented functional tea | |
| KR101698774B1 (en) | A Method for Preparing Fermented Materials of Korean Dendropanax and a Method for Manufacturing Beverage Using the Fermented Materials | |
| KR101976503B1 (en) | Medium composition for enhancing alcohol fermentation comprising leaf of yam and alcoholic beverage using the same | |
| KR100907037B1 (en) | Cultivation method of Ganoderma lucidum or shiitake mushroom mycelium containing green tea ingredients and food prepared using the same | |
| JP4801948B2 (en) | Method for changing the content ratio of catechins in tea leaves and tea extracts | |
| WA et al. | Bioactive potential of some fascinating edible mushrooms Macrolepiota, Russula, Amanita, Vovariella and Grifola as a treasure of multipurpose therapeutic natural product | |
| KR20130055938A (en) | Method for producing fermented turmeric powder and fermented turmeric powder produced by the same method | |
| JP7188839B2 (en) | Sauce composition and method for producing sauce composition | |
| KR100748846B1 (en) | Process for Propolis Fermentation | |
| KR101923571B1 (en) | Method for Preparing Shindari Using an Extract of Korean Dendropanax | |
| KR20180119940A (en) | Method for extract of manufacturing fermentated tea and extract of fermentated tea prepared therefrom | |
| KR101491769B1 (en) | Manufacturing method of natural vinegar using extraction of detoxification of Rhus verniciflua and natural vinegar by the same | |
| JP3362312B2 (en) | Beer production method and beer obtained thereby | |
| KR20160057615A (en) | Method for producing vinegar comprising an effective compound derived from fermented coffee | |
| KR101916755B1 (en) | Tea made by microbial fermentation of black currant leaf | |
| KR20160075114A (en) | Preparation Metod of Vinegar Containing Coffee Extract | |
| KR20230117815A (en) | Scorched rice capable of long-term storage and preparation method thereof | |
| KR20100115425A (en) | Functional drinks | |
| KR101677685B1 (en) | Method for manufacturing rice bran fermenting agent and method for manufacturing fermented rice bran by using the rice bran fermenting agent | |
| JP3742391B2 (en) | Non-alcoholic beer manufacturing method | |
| CN110463803A (en) | De- bitter olive growing leaves functionality fermented tea of one kind and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080801 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100618 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100622 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100820 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110308 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110502 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110607 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110706 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110726 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110808 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140812 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |